PerkinElmer Inc (NYSE:PKI)
| 31.72 Real-Time Quote |  -0.04 / -0.13%Today’s Change | 23.73 Today|||52-Week Range 35.86 | -0.06% Year-to-Date |
Latest PKI News | Press Releases
| PKI Downgraded to Underperform - Analyst Blog May 20 / Zacks.com |
Today’s Trading
| Previous close | 31.76 |
| Today’s open | 31.55 |
| Day’s range | 31.47 - 31.80 |
| Volume | 636,884 |
| Average volume (3 months) | 1,219,874 |
| Market cap | $3.6B |
| Dividend yield | 0.88% |
Data as of 2:50pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +5,859.00% |
| Earnings growth (this year) | -0.93% |
| Earnings growth (next 5 years) | +10.46% |
| Revenue growth (last year) | +10.09% |
| P/E ratio | 46.5 |
| Price/Sales | 1.67 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | +0.09 | +0.53% |
| FEICFEI Co | +0.09 | +0.13% |
| BIOBio-Rad Laboratories... | -0.43 | -0.37% |
| QGENQiagen NV | +0.06 | +0.32% |
Data as of 2:49pm ET, 05/24/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $68.4M |
| Net profit margin | 3.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Robert F. Friel |
Chief Financial Officer & Senior Vice President Frank Anders Wilson, CPA |
Corporate headquarters Waltham, Massachusetts |
Forecasts
